Loading...

Theratechnologies Inc.

TH.TO•TSX
HealthcareDrug Manufacturers - Specialty & Generic
$3.61
$-0.03(-0.82%)

Theratechnologies Inc. (TH.TO) Stock Overview

Explore Theratechnologies Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
5.02%
↑ 5.02%
Profit Growth
$-0.08
↑ 65.33%
EPS Growth
$-0.08
↑ 82.42%
Operating Margin
13.89%
↑ 176.92%
ROE
16.01%
↑ 65.33%
Dividend Yield
0.00%
Analyst Recommendations data is not available for TH.TOAnalyst Recommendations details for TH.TO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

CEO

Mr. Paul Lévesque

Employees

103

Headquarters

2015 Peel Street, Montreal, QC

Founded

1996

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.